GASSER RODOLFO,HERNANDEZ MARIA-CLEMENCIA,THOMAS ANDREW
申请号：
IN3421/CHENP/2013
公开号：
IN2013CN03421A
申请日:
2013.05.01
申请国别(地区):
IN
年份:
2016
代理人:
摘要：
The present invention relates to the pharmaceutical use of selective GABA A a5 negative allosteric modulators for the treatment prevention and/or delay of progression of central nervous system (CNS) conditions related to excessive GABAergic inhibition in the brain.
